Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
17.03
+0.11 (0.65%)
At close: Dec 20, 2024, 4:00 PM
17.01
-0.02 (-0.12%)
After-hours: Dec 20, 2024, 7:24 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $689.84 million as of December 20, 2024. Its market cap has decreased by -35.16% in one year.
Market Cap
689.84M
Enterprise Value
178.44M
1-Year Change
-35.16%
Ranking
Category
Stock Price
$17.03
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $689.84M, an increase of 79.03%. That is a compound annual growth rate of 13.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 689.84M | -42.09% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 688.13M |
| Savara | 680.75M |
| Rapport Therapeutics | 679.77M |
| Evolus | 678.81M |
| IRADIMED CORPORATION | 672.83M |
| CureVac | 670.70M |
| Orthofix Medical | 663.78M |
| Tectonic Therapeutic | 659.00M |